Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bilastine driving performance study
NL-OMON27203Recruiting
- Sponsor
- Faes Farma
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of bilastine in allergic rhinitis (AR) (4 arms), sponsored by Faes Farma. Primary endpoint: Standard deviation of lateral position. Started Jun 2008; status: recruiting.
02
Drugs
bilastine
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NL-OMON27203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27203.